Familial Cancer

Papers
(The H4-Index of Familial Cancer is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Laboratory variation in the grading of dysplasia of duodenal adenomas in familial adenomatous polyposis patients25
Prevalence of cardiometabolic outcomes in women who underwent salpingo-oophorectomy to prevent hereditary breast and ovarian cancer: a meta-analysis25
Cascade genetic testing: an underutilized pathway to equitable cancer care?24
Colonoscopy surveillance in Lynch syndrome is burdensome and frequently delayed23
Hereditary breast and ovarian cancer genetic testing in unselected patients: example of private supplementation of public healthcare service19
Detection of a major Lynch Syndrome-causing MLH1 founder variant in a large-scale genotyped cohort18
Hereditary acute myeloid leukemia associated with C-terminal CEBPA germline variants17
Digital innovation for cancer risk assessment allows large-scale service redevelopment of regional cancer genetics service delivery16
Cascade genetic counseling and testing in hereditary syndromes: inherited cardiovascular disease as a model: a narrative review13
Psychosocial barriers and facilitators for cascade genetic testing in hereditary breast and ovarian cancer: a scoping review13
Haplotype analysis detects MLH1 founder variant in Indian Lynch syndrome patient cohort11
Clinician perspectives on policy approaches to genetic risk disclosure in families11
0.094838857650757